PAVmed Inc. financial data

Symbol
PAVM on Nasdaq
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 23% % -46%
Quick Ratio 1% %
Debt-to-equity 66% %
Return On Equity 15% %
Return On Assets 7% % -89%
Operating Margin -1483% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16,787,173 shares 80%
Common Stock, Shares, Outstanding 23,053,498 shares 116%
Entity Public Float $7,000,000 USD -82%
Common Stock, Value, Issued $23,000 USD 109%
Weighted Average Number of Shares Outstanding, Basic 21,554,546 shares 115%
Weighted Average Number of Shares Outstanding, Diluted 21,554,546 shares -52%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $3,000,000 USD
Revenue from Contract with Customer, Excluding Assessed Tax $29,000 USD -99%
Cost of Revenue $181,000 USD -96%
Research and Development Expense $3,473,000 USD -60%
Selling and Marketing Expense $822,000 USD -95%
General and Administrative Expense $15,747,000 USD -42%
Costs and Expenses $20,223,000 USD -66%
Operating Income (Loss) $20,194,000 USD 64%
Nonoperating Income (Expense) $21,624,000 USD -67%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1,430,000 USD -86%
Net Income (Loss) Attributable to Parent $3,095,000 USD -87%
Earnings Per Share, Basic 0 USD/shares 29%
Earnings Per Share, Diluted 2 USD/shares -120%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,185,000 USD -94%
Accounts Receivable, after Allowance for Credit Loss, Current $3,000 USD -81%
Inventory, Net $6,000 USD
Assets, Current $4,191,000 USD 97%
Property, Plant and Equipment, Net $81,000 USD -62%
Operating Lease, Right-of-Use Asset $2,131,000 USD -19%
Intangible Assets, Net (Excluding Goodwill) $947,000 USD -61%
Other Assets, Noncurrent $51,000 USD -32%
Assets $38,069,000 USD 25%
Accounts Payable, Current $342,000 USD -26%
Employee-related Liabilities, Current $1,151,000 USD -54%
Accrued Liabilities, Current $2,660,000 USD -41%
Liabilities, Current $10,459,000 USD -72%
Operating Lease, Liability, Noncurrent $1,823,000 USD -23%
Liabilities $12,282,000 USD -69%
Retained Earnings (Accumulated Deficit) $256,901,000 USD -0.23%
Stockholders' Equity Attributable to Parent $32,520,000 USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $22,527,000 USD
Liabilities and Equity $38,069,000 USD 25%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,581,000 USD 88%
Net Cash Provided by (Used in) Financing Activities $3,102,000 USD -84%
Net Cash Provided by (Used in) Investing Activities $6,000 USD 86%
Common Stock, Shares Authorized 250,000,000 shares 400%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,515,000 USD -74%
Deferred Tax Assets, Valuation Allowance $42,023,000 USD -55%
Deferred Tax Assets, Gross $42,896,000 USD -55%
Operating Lease, Liability $2,380,000 USD -17%
Payments to Acquire Property, Plant, and Equipment $6,000 USD -86%
Lessee, Operating Lease, Liability, to be Paid $2,815,000 USD -20%
Property, Plant and Equipment, Gross $1,404,000 USD -60%
Operating Lease, Liability, Current $557,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $594,000 USD -18%
Lessee, Operating Lease, Liability, to be Paid, Year One $724,000 USD 2.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $435,000 USD -32%
Lessee, Operating Lease, Liability, to be Paid, Year Three $471,000 USD -21%
Deferred Tax Assets, Operating Loss Carryforwards $30,439,000 USD -55%
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $481,000 USD 2.1%
Operating Lease, Payments $175,000 USD -63%
Additional Paid in Capital $265,331,000 USD 6.9%
Amortization of Intangible Assets $559,000 USD -72%
Depreciation, Depletion and Amortization $43,000 USD -93%
Deferred Tax Assets, Net of Valuation Allowance $51,600,000 USD
Interest Expense $26,000 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%